Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash & Current Investments: 2017-2020

Historic Cash & Current Investments for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $242.2 million.

  • Cogent Biosciences' Cash & Current Investments rose 56.77% to $202.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $893.9 million, marking a year-over-year increase of 310.45%. This contributed to the annual value of $242.2 million for FY2020, which is 547.15% up from last year.
  • As of FY2020, Cogent Biosciences' Cash & Current Investments stood at $242.2 million, which was up 547.15% from $37.4 million recorded in FY2019.
  • Cogent Biosciences' Cash & Current Investments' 5-year high stood at $242.2 million during FY2020, with a 5-year trough of $37.4 million in FY2019.
  • Over the past 3 years, Cogent Biosciences' median Cash & Current Investments value was $97.9 million (recorded in 2018), while the average stood at $125.9 million.
  • As far as peak fluctuations go, Cogent Biosciences' Cash & Current Investments plummeted by 61.79% in 2019, and later spiked by 547.15% in 2020.
  • Over the past 4 years, Cogent Biosciences' Cash & Current Investments (Yearly) stood at $49.6 million in 2017, then soared by 97.56% to $97.9 million in 2018, then plummeted by 61.79% to $37.4 million in 2019, then soared by 547.15% to $242.2 million in 2020.